Antilipopolysaccharide II: An antibody protective against fatal melioidosis

Clinical Infectious Diseases

Volumn 29, Issue 4, 1999, Pages 813-818

  Charuchaimontri, Chadarat ^a,b,c,d,e,f   Suputtamongkol, Yupin ^a,b,c,d,e,f   Nilakul, Churairat ^a,b,c,d,e,f   Chaowagul, Wipada ^a,b,c,d,e,f   Chetchotisakd, Ploenchan ^a,b,c,d,e,f   Lertpatanasuwun, Nimit ^a,b,c,d,e,f   Intaranongpai, Sunanta ^a,b,c,d,e,f   Brett, Paul J ^a,b,c,d,e,f   Woods, Donald E ^a,b,c,d,e,f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Sappasitthiprasong Hospital   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

^d Department of Medicine   (Thailand)

^e Surin Hospital   (Thailand)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; LIPOPOLYSACCHARIDE;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BACTEREMIA; BURKHOLDERIA; DISEASE DURATION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGRESSION ANALYSIS; SEPTICEMIA; STATISTICAL ANALYSIS;

EID: 0033509738     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520441     Document Type: Article

References (15)

1. Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989;11:413-25.
2. Merianos A, Patel M, Lane JM, et al. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health 1993;24:425-35.
3. Chaowagul W, White NJ, Dance DAB, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989;159:890-9.
4. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;2:697-701.
5. Sookpranee M, Boonma P, Susaengrat W, Bhuripanyo K, Punyagupta S. Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and cotrimoxazole for treatment of severe melioidosis. Antimicrob Agents Chemother 1992;36:158-62.
6. Suputtamongkol Y, Rajchanuwong A, Chaowagul W, et al. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 1994;19:846-53.
7. Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DA, White NJ. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg 1995;89:546-9.
8. Chaowagul W, Suputtamongkol Y, Dance DA, Rajchanuvong A, Pattara-Arechachai J, White NJ. Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993;168:1181-5.
9. Perry MB, Maclean LL, Schollaardt T, Bryan LE, Ho M. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun 1995;63:3348-52.
10. Brett PJ, Mah DCW, Woods DE. Isolation and characterization of Pseudomonas pseudomallei flagellin protein. Infect Immun 1994;62:1914-9.
11. Bryan LE, Wong S, Woods DE, Dance DAB, Chaowagul W. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide from Pseudomonas pseudomallei. Can J Infect Dis 1994;9:170-8.
12. Westphal O, Jann K. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965;25:83-91.
13. Ho M, Schollaardt T, Smith MD, Brett PJ, Chaowagul W, Bryan LE. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun 1997;65:3648-53.
14. Suputtamongkol Y, Hall AJ, Dance DAB, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol 1994;23:1082-90.
15. Wuthiekanun V, Smith MD, Dance DAB, While NJ. Isolation of Pseudomonas pseudomallei from soil in north-eastern Thailand. Trans R Soc Trop Med Hyg 1995;41:41-3.